The short-lived transplantation of NPCs could dampen neuroinflammation and remyelination with the decrease of CD4+ T cells and the increase of CD4+FOXP3+ Tregs in the MS animal model but not lead to significant clinical improvement. This evidence concerns the gene FOXP3 and myeloid sarcoma.